Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1997 2
1998 3
1999 4
2000 3
2001 2
2002 2
2003 5
2004 3
2005 3
2006 8
2007 4
2008 6
2009 9
2010 8
2011 9
2012 11
2013 9
2014 11
2015 9
2016 9
2017 11
2018 8
2019 13
2020 5
2021 6
2022 10
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I, Kirasic E, Wienand K, Mokhtari K, Eimer S, Loiseau H, Rousseau A, Paillassa J, Ahle G, Lerintiu F, Uro-Coste E, Oberic L, Figarella-Branger D, Chinot O, Gauchotte G, Taillandier L, Marolleau JP, Polivka M, Adam C, Ursu R, Schmitt A, Barillot N, Nichelli L, Lozano-Sánchez F, Ibañez-Juliá MJ, Peyre M, Mathon B, Abada Y, Charlotte F, Davi F, Stewart C, de Reyniès A, Choquet S, Soussain C, Houillier C, Chapuy B, Hoang-Xuan K, Alentorn A. Hernández-Verdin I, et al. Among authors: taillandier l. Ann Oncol. 2023 Feb;34(2):186-199. doi: 10.1016/j.annonc.2022.11.002. Epub 2022 Nov 17. Ann Oncol. 2023. PMID: 36402300 Free article.
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
Houillier C, Dureau S, Taillandier L, Houot R, Chinot O, Moluçon-Chabrot C, Schmitt A, Gressin R, Choquet S, Damaj G, Peyrade F, Abraham J, Delwail V, Gyan E, Sanhes L, Cornillon J, Garidi R, Delmer A, Al Jijakli A, Morel P, Waultier A, Paillassa J, Chauchet A, Gastinne T, Laadhari M, Plissonnier AS, Feuvret L, Cassoux N, Touitou V, Ricard D, Hoang-Xuan K, Soussain C; LOC Network for CNS Lymphoma. Houillier C, et al. Among authors: taillandier l. J Clin Oncol. 2022 Nov 10;40(32):3692-3698. doi: 10.1200/JCO.22.00491. Epub 2022 Jul 14. J Clin Oncol. 2022. PMID: 35834762 Clinical Trial.
[Medulloblastomas: review].
Taillandier L, Blonski M, Carrie C, Bernier V, Bonnetain F, Bourdeaut F, Thomas IC, Chastagner P, Dhermain F, Doz F, Frappaz D, Grill J, Guillevin R, Idbaih A, Jouvet A, Kerr C, Donadey FL, Padovani L, Pallud J, Sunyach MP. Taillandier L, et al. Rev Neurol (Paris). 2011 May;167(5):431-48. doi: 10.1016/j.neurol.2011.01.014. Epub 2011 May 6. Rev Neurol (Paris). 2011. PMID: 21529869 Review. French.
[Editorial].
Taillandier L, Le Rhun É, Métellus P, Mornex F, Mazeron JJ. Taillandier L, et al. Cancer Radiother. 2015 Feb;19(1):1-2. doi: 10.1016/j.canrad.2014.11.005. Epub 2015 Feb 7. Cancer Radiother. 2015. PMID: 25662598 French. No abstract available.
The etiopathogenesis of diffuse low-grade gliomas.
Darlix A, Gozé C, Rigau V, Bauchet L, Taillandier L, Duffau H. Darlix A, et al. Among authors: taillandier l. Crit Rev Oncol Hematol. 2017 Jan;109:51-62. doi: 10.1016/j.critrevonc.2016.11.014. Epub 2016 Nov 27. Crit Rev Oncol Hematol. 2017. PMID: 28010898 Review.
Supportive care in neurooncology.
Taillandier L, Blonski M, Darlix A, Hoang Xuan K, Taillibert S, Cartalat Carel S, Piollet I, Le Rhun E. Taillandier L, et al. Rev Neurol (Paris). 2011 Oct;167(10):762-72. doi: 10.1016/j.neurol.2011.08.008. Epub 2011 Sep 7. Rev Neurol (Paris). 2011. PMID: 21903233 Review.
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors.
Farina A, Villagrán-García M, Ciano-Petersen NL, Vogrig A, Muñiz-Castrillo S, Taillandier L, Michaud M, Lefilliatre M, Wang A, Lepine Z, Picard G, Wucher V, Dhairi M, Fabien N, Goncalves D, Rogemond V, Joubert B, Honnorat J. Farina A, et al. Among authors: taillandier l. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 29;10(1):e200058. doi: 10.1212/NXI.0000000000200058. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36446613 Free PMC article.
Venous thrombosis in patients with high-grade glioma.
Taillibert S, Taillandier L, Le Rhun E. Taillibert S, et al. Among authors: taillandier l. Curr Opin Oncol. 2015 Nov;27(6):516-21. doi: 10.1097/CCO.0000000000000226. Curr Opin Oncol. 2015. PMID: 26447877 Review.
Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Boursier C, Zaragori T, Bros M, Bordonne M, Melki S, Taillandier L, Blonski M, Roch V, Marie PY, Karcher G, Imbert L, Verger A. Boursier C, et al. Among authors: taillandier l. Eur Radiol. 2023 Oct;33(10):7089-7098. doi: 10.1007/s00330-023-09697-8. Epub 2023 May 6. Eur Radiol. 2023. PMID: 37148355 Review.
[Symptomatic management of brain metastasis].
Le Rhun E, Taillandier L, Beauchene P, Bailon O, Dubois F. Le Rhun E, et al. Among authors: taillandier l. Bull Cancer. 2013 Jan 1;100(1):99-103. doi: 10.1684/bdc.2012.1689. Bull Cancer. 2013. PMID: 23360760 Free article. Review. French.
160 results